Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

LLM 2021 | Rare blood diseases at LLM 2021

Sangmin Lee • 20 Oct 2021
LLM 2021
Leukemia Myeloproliferative Neoplasms Non-Malignant Paroxysmal Nocturnal Hemoglobinuria Systemic Mastocytosis

Sangmin Lee, MD, Weill Cornell Medicine, New York, NY, shares key highlights that will be addressed in the rare disease session at the Lymphoma, Leukemia & Myeloma Congress 2021. Dr Lee highlights the latest therapies in development for multiple rare blood diseases including paroxysmal nocturnal hemoglobinuria (PNH), systemic mastocytosis, and large granular lymphocytic (LGL) leukemia. This interview took place at the Lymphoma, Leukemia & Myeloma Congress 2021.

More from Sangmin Lee

1:45
Updates on the treatment of MDS
Sangmin Lee • 20 Oct 2021
1:07
Challenges in treating AML
Sangmin Lee • 20 Oct 2021
2:10
Updated overall survival data on eltanexor for HMA-refractory MDS
Sangmin Lee • 4 Jun 2021
1:17
Phase II study of tosedostat in MDS
Sangmin Lee • 4 Jun 2021

Related Videos

1:40
The role of CPX-351 in the AML treatment landscape & insights into the AMLSG 30-18 trial
Felicitas Thol • 19 Apr 2024
3:21
Integrating genomics and MRD in transplant decision-making for patients with AML
Jurjen Versluis • 22 Apr 2024
4:19
Blinatumomab to achieve remission and consolidation with haploSCT for pediatric ALL
Alberto Olaya-Vargas • 15 Apr 2024
3:32
Improving CAR-T therapy for ALL & lymphoma: allogeneic products & reducing CRS/ICANS
Sridhar Chaganti • 16 Apr 2024
The content of VJHemOnc is intended for healthcare professionals